Adrian P Banning

Adrian P Banning

John Radcliffe Hospital, Oxford, UK

  • Radcliffe

Biography

Dr Adrian Banning is a consultant cardiologist specialising in percutaneous coronary intervention.

He is the president of the British Cardiac Intervention Society and was previously the Divisional Director for Cardiology, Cardiothoracic and Vascular Surgery at the John Radcliffe University Hospital, Oxford. Through his position at the John Radcliffe, and his own practice at Oxford’s The Manor Hospital, Prof Banning provides specialist regional services for coronary and valvular heart disease patients to an area of 1.2 million people.

Prof Banning is pioneering research in his field and lectures nationally and internationally. He has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.

Read more

Media

Adrian P Banning

ACI 2020 Upcoming Preview

Adrian P Banning

Watch time: 6m 7s

Adrian P Banning

Optimising Outcomes In Left Main PCI

Adrian P Banning

Left Main PCI - What are the main challenges

Adrian P Banning

Left Main PCI IVUS guided left main PCI

Adrian P Banning

Optimising Outcomes In Left Main PCI

Adrian P Banning

What Are The Challenges When Treating Left Main Angiographically?

Adrian P Banning

Optimising outcomes in left main PCI

Adrian P Banning

Optimising Outcomes in Left Main PCI

Adrian P Banning

Articles by Adrian P Banning

Why, When and How Should Clinicians Use Physiology in Patients with Acute Coronary Syndromes?

Roberto Scarsini, Dimitrios Terentes-Printzios, Giovanni Luigi De Maria, et al

Published:

Citation: Interventional Cardiology Review 2020;15:e05.

DOI:

https://doi.org/10.15420/icr.2019.26
Use of Intravascular Ultrasound Imaging in Percutaneous Coronary Intervention on Left Main Coronary Artery Disease

Adrian P Banning, Giovanni Luigi De Maria,

Citation: RadcliffeCardiology.com, November 2017

DOI:

https://doi.org/10.15420/rc.2017.m004
Use of Intravascular Ultrasound Imaging in Percutaneous Coronary Intervention to Treat Left Main Coronary Artery Disease

Giovanni Luigi De Maria, Adrian P Banning,

Citation: Interventional Cardiology Review 2017;12(1):8–12

DOI:

https://doi.org/10.15420/icr.2017:1:3
Differential Drug-eluting Stent Effects in Patients with Diabetes - Bench-to-bedside Evidence for Neointimal Suppression and Restenosis Reduction

Adrian P Banning, Kristin L Hood, Aloke V Finn, et al

Citation: Interventional Cardiology 2010;5:27–34

DOI:

https://doi.org/10.15420/icr.2010.5.1.27